Alpha 1-antitrypsin deficiency, emphysema, and liver disease. Genetic basis and strategies for therapy.

[1]  R. Crystal,et al.  Molecular basis of alpha 1-antitrypsin deficiency and emphysema associated with the alpha 1-antitrypsin Mmineral springs allele , 1990, Molecular and cellular biology.

[2]  J. Pierce,et al.  Synthesis of stress proteins is increased in individuals with homozygous PiZZ alpha 1-antitrypsin deficiency and liver disease. , 1989, The Journal of clinical investigation.

[3]  L. Traber,et al.  Pulmonary deposition and clearance of aerosolized alpha-1-proteinase inhibitor administered to dogs and to sheep. , 1989, The Journal of clinical investigation.

[4]  R. Crystal,et al.  Recombinant DNA-produced alpha 1-antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with alpha 1-antitrypsin deficiency. , 1989, The Journal of clinical investigation.

[5]  W. Travis,et al.  Molecular basis of the liver and lung disease associated with the alpha 1-antitrypsin deficiency allele Mmalton. , 1989, The Journal of biological chemistry.

[6]  R. Crystal,et al.  Anti-Neutrophil-Elastase Defenses of the Lower Respiratory Tract in α1-Antitrypsin Deficiency Directly Augmented with an Aerosol of α1-Antitrypsin , 1989 .

[7]  P. Sehgal,et al.  Interferon beta 2/interleukin 6 modulates synthesis of alpha 1-antitrypsin in human mononuclear phagocytes and in human hepatoma cells. , 1989, The Journal of clinical investigation.

[8]  Cliff,et al.  Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice. , 1989, The Journal of clinical investigation.

[9]  V. Lingappa.  Intracellular traffic of newly synthesized proteins. Current understanding and future prospects. , 1989, The Journal of clinical investigation.

[10]  S. Woo,et al.  Disruption of the 290-342 salt bridge is not responsible for the secretory defect of the PiZ alpha 1-antitrypsin variant. , 1989, The Journal of biological chemistry.

[11]  R. Carrell,et al.  The molecular pathology of the serpins. , 1989, Molecular biology & medicine.

[12]  D. States,et al.  The alpha 1-antitrypsin gene and its mutations. Clinical consequences and strategies for therapy. , 1989, Chest.

[13]  R. Crystal,et al.  Repair of the secretion defect in the Z form of alpha 1-antitrypsin by addition of a second mutation. , 1988, Science.

[14]  R. Crystal,et al.  Biochemical Efficacy and Safety of Monthly Augmentation Therapy for α1-Antitrypsin Deficiency , 1988 .

[15]  J. Travis.  Structure, function, and control of neutrophil proteinases , 1988 .

[16]  R. Crystal,et al.  Molecular basis of alpha-1-antitrypsin deficiency. , 1988, The American journal of medicine.

[17]  R. Crystal,et al.  Alpha-1-antitrypsin augmentation therapy for alpha-1-antitrypsin deficiency. , 1988, The American journal of medicine.

[18]  S. Eriksson,et al.  Lung function, smoking and survival in severe alpha 1-antitrypsin deficiency, PiZZ. , 1988, Journal of clinical epidemiology.

[19]  R. Crystal,et al.  Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase. , 1987, The Journal of clinical investigation.

[20]  R. Crystal,et al.  Clonal gene therapy: transplanted mouse fibroblast clones express human alpha 1-antitrypsin gene in vivo. , 1987, Science.

[21]  R. Crystal,et al.  Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema. , 1987, The New England journal of medicine.

[22]  R. Crystal,et al.  Identification of a second mutation in the protein-coding sequence of the Z type alpha 1-antitrypsin gene. , 1986, The Journal of biological chemistry.

[23]  R. Carrell.  alpha 1-Antitrypsin: molecular pathology, leukocytes, and tissue damage. , 1986, The Journal of clinical investigation.

[24]  R. Crystal,et al.  Expression of the alpha-1-antitrypsin gene in mononuclear phagocytes of normal and alpha-1-antitrypsin-deficient individuals. , 1986, The Journal of clinical investigation.

[25]  J. Carlson,et al.  Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency. , 1986, The New England journal of medicine.

[26]  A Janoff,et al.  Elastases and emphysema. Current assessment of the protease-antiprotease hypothesis. , 1985, The American review of respiratory disease.

[27]  R. Huber,et al.  Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. , 1984, Journal of molecular biology.

[28]  R. Crystal,et al.  Replacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects. , 1981, The Journal of clinical investigation.

[29]  R. Crystal,et al.  Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema. , 1981, The Journal of clinical investigation.

[30]  W. Krivit,et al.  Cirrhosis associated with alpha-1-antitrypsin deficiency: a previously unrecognized inherited disorder. , 1969, The Journal of laboratory and clinical medicine.

[31]  C. Laurell,et al.  The Electrophoretic α;1-Globulin Pattern of Serum in α;1-Antitrypsin Deficiency , 1963 .